z-logo
Premium
Autoantibodies from Sjögren's Syndrome Trigger Apoptosis in Salivary Gland Cell Line
Author(s) -
SISTO MARGHERITA,
LISI SABRINA,
LOFRUMENTO DARIO,
D'AMORE MASSIMO,
SCAGLIUSI PASQUALE,
MITOLO VINCENZO
Publication year - 2007
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1422.044
Subject(s) - autoantibody , apoptosis , antibody , immunology , microbiology and biotechnology , autoimmune disease , pathogenesis , western blot , salivary gland , antigen , biology , chemistry , medicine , biochemistry , gene
:  The presence of serum autoantibodies has been associated with Sjögren's syndrome (SS), an autoimmune rheumatic disease that targets salivary and lachrymal glands. The association of apoptosis with autoantibodies production seems to play a role in the pathogenesis of glandular damage. The best‐defined antibodies in SS are those reacting with the ribonucleoprotein antigens SS‐A (Ro) and SS‐B (La). Anti‐Ro antibodies are found in about 70–90%, and anti‐La in approximately the same frequency, of patients with primary SS. The objective of this work was to explore whether anti‐Ro and anti‐La autoantibodies purified from Sjögren IgG fractions are able to trigger apoptotic process in the human salivary gland cell line A‐253. Anti‐Ro and anti‐La autoantibodies were purified on protein G Sepharose affinity column and used for the A‐253 cell treatment. Apoptosis induced by autoantibodies was revealed by FACS analysis, and the active caspase‐3 and the cleaved caspase‐3 substrate poly (ADP‐ribose) polymerase (PARP) was demonstrated by colorimetric assay and Western blot. This report shows that anti‐Ro and anti‐La autoantibodies, but not healthy IgG, activate the caspase‐3 and determine the cleavage of PARP in A‐253 cells. Apoptosis triggered by Sjögren autoantibodies could be responsible for the impairment of the secretory function in the salivary glands .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here